Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer pati

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> COPY / PASTE LINK PLEASE 🎵 MP3 <<

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=tvmCTcHAXms

Prof Charles Geyer gives a press conference at SABCS 2018 about the results of the phase III KATHERINE clinical trial, which found that substituting trastuzumab emtansine for adjuvant trastuzumab in improved IDFS in patients with HER2-positive early breast cancer who had residual disease after receiving neoadjuvant • chemotherapy and trastuzumab. • Watch his interview with ecancer here: https://ecancer.org/conference/1122-s... • Read more about this. work here: https://ecancer.org/news/15194-sabcs-... • Sign up to ecancer for free to receive tailored email alerts for more videos like this. • ecancer.org/account/register.php

#############################